Europe 1 2:38 p.m., September 21, 2021, modified at 2:40 p.m., September 21, 2021
The Carmat company, specializing in the making of artificial hearts, announced overnight Monday to Tuesday that a successful transplant had been performed on a patient in the United States. A feat, whereas until now it had only been done on men, which shows that the Carmat heart can adapt to all anatomies.
This may be a detail for you, it is a big step forward for heart surgery.
The Carmat company, specializing in the making of artificial hearts, announced overnight Monday to Tuesday that a successful transplant had been performed on a patient in the United States.
So far, only men had been able to benefit from it.
"This is a huge step forward," said Stéphane Piat, CEO of Carmat, in "La France Bouge" on Europe 1 on Tuesday.
"Very often" in fact, the Carmat heart has been deemed too large to be implanted in women.
"The chest can be smaller, the rib cage a little lower" in patients, recognizes Stéphane Piat.
"And the fear, during a transplant, is always not to be able to close the thorax."
"Most adults can benefit from it"
With this successful transplant, "we have shown that the majority of adults can benefit from it," says the CEO of the company.
"We have been able to demonstrate by A + B that the size of the Carmat heart is not a problem for the compatibility at the anatomical level."
The French company continues its good momentum, after the announcement last week of six locations in Germany and Italy.
Operations that have enabled it to generate its first two million euros in turnover since its launch in 2008. In December 2020, Carmat obtained CE marking in Europe, which gave it the green light for marketing. of its artificial heart on the Old Continent.